STRATEGY STUDIO / NONPROFIT PEOPLE SEARCH

BIOTECHNOLOGY INNOVATION ORGANIZATION: Form 990, tax year 2014

View the entire original 990 at ProPublica ↗

Organization
BIOTECHNOLOGY INNOVATION ORGANIZATION (EIN 52-1224577)
Tax period
2014-01-01 to 2014-12-31
Filed
2015-11-16
IRS object ID
201543209349314904
Schema version
2014v5.0
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Return2015-11-16T17:44:13-06:00ReturnTs
Tax Period End2014-12-31TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

FieldValueIRS element (for citing)
Preparer Firm EIN410746749PreparerFirmEIN

Preparer Firm Name PreparerFirmName

FieldValueIRS element (for citing)
Business Name Line1CLIFTONLARSONALLEN LLPBusinessNameLine1Txt

Preparer US Address PreparerUSAddress

FieldValueIRS element (for citing)
Address Line14250 N FAIRFAX DRIVE SUITE 1020AddressLine1Txt
CityARLINGTONCityNm
State AbbreviationVAStateAbbreviationCd
ZIP22203ZIPCd
FieldValueIRS element (for citing)
Return Type990ReturnTypeCd
Tax Period Begin2014-01-01TaxPeriodBeginDt

Filer Filer

FieldValueIRS element (for citing)
EIN521224577EIN

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1BIOTECHNOLOGY INDUSTRY ORGANIZATIONBusinessNameLine1Txt
FieldValueIRS element (for citing)
Business Name ControlBIOTBusinessNameControlTxt
Phone2029629200PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line11201 MARYLAND AVENUE SW NO 900AddressLine1Txt
CityWASHINGTONCityNm
State AbbreviationDCStateAbbreviationCd
ZIP20024ZIPCd

Business Officer BusinessOfficerGrp

FieldValueIRS element (for citing)
PersonJOANNE M DUNCANPersonNm
Person TitleCFO & SVP, FINANCE & ADMINPersonTitleTxt
Phone2029629200PhoneNum
Signature2015-11-13SignatureDt
Discuss With Paid PreparerYes (1)DiscussWithPaidPreparerInd

Preparer Person PreparerPersonGrp

FieldValueIRS element (for citing)
Preparer PersonDAVID TRIMNERPreparerPersonNm
PTINP00444822PTIN
Phone5712279500PhoneNum
FieldValueIRS element (for citing)
Tax2014TaxYr
Build TS2016-04-25 22:37:26ZBuildTS

Form 990 IRS990

FieldValueIRS element (for citing)
Principal OfficerJAMES C GREENWOODPrincipalOfficerNm

US Address USAddress

FieldValueIRS element (for citing)
Address Line11201 MARYLAND AVENUE SW NO 900AddressLine1Txt
CityWASHINGTONCityNm
State AbbreviationDCStateAbbreviationCd
ZIP20024ZIPCd
FieldValueIRS element (for citing)
Gross Receipts$96,967,799GrossReceiptsAmt
Group Return For Affiliates0GroupReturnForAffiliatesInd
Organization501cYes (X)Organization501cInd
Website AddressWWW.BIO.ORGWebsiteAddressTxt
Type Of Organization CorpYes (X)TypeOfOrganizationCorpInd
Formation1993FormationYr
Legal Domicile StateDCLegalDomicileStateCd
Activity Or MissionTHE BIOTECHNOLOGY INDUSTRY ORGANIZATION (BIO) MISSION IS TO SUPPORT THE BIOTECHNOLOGY INDUSTRY TO EXPAND THE BOUNDARIES OF SCIENCE TO BENEFIT MANKIND BY PROVIDING BETTER HEALTH CARE, ENHANCED AGRICULTURE AND A CLEANER AND SAFER ENVIRONMENT. IT IS BIO'S MISSION TO BE THE CHAMPION OF BIOTECHNOLOGY AND THE ADVOCATE OF OUR MEMBER ORGANIZATIONS - BOTH LARGE AND SMALL.ActivityOrMissionDesc
Voting Members Governing Body107VotingMembersGoverningBodyCnt
Voting Members Independent107VotingMembersIndependentCnt
Total Employee190TotalEmployeeCnt
Total Volunteers225TotalVolunteersCnt
Total Gross UBI$374,180TotalGrossUBIAmt
Net Unrelated Bus Txbl Incm$0NetUnrelatedBusTxblIncmAmt
PY Contributions Grants$0PYContributionsGrantsAmt
CY Contributions Grants$0CYContributionsGrantsAmt
PY Program Service Revenue$60,759,645PYProgramServiceRevenueAmt
CY Program Service Revenue$58,986,031CYProgramServiceRevenueAmt
PY Investment Income$4,800,278PYInvestmentIncomeAmt
CY Investment Income$3,035,059CYInvestmentIncomeAmt
PY Other Revenue$20,773PYOtherRevenueAmt
CY Other Revenue$4,796,209CYOtherRevenueAmt
PY Total Revenue$65,580,696PYTotalRevenueAmt
CY Total Revenue$66,817,299CYTotalRevenueAmt
PY Grants And Similar Paid$664,500PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid$588,500CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members$0PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members$0CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid$29,774,878PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid$30,326,647CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns$0PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns$0CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense$0CYTotalFundraisingExpenseAmt
PY Other Expenses$35,737,171PYOtherExpensesAmt
CY Other Expenses$35,217,817CYOtherExpensesAmt
PY Total Expenses$66,176,549PYTotalExpensesAmt
CY Total Expenses$66,132,964CYTotalExpensesAmt
PY Revenues Less Expenses-$595,853PYRevenuesLessExpensesAmt
CY Revenues Less Expenses$684,335CYRevenuesLessExpensesAmt
Total Assets BOY$66,638,973TotalAssetsBOYAmt
Total Assets EOY$68,085,013TotalAssetsEOYAmt
Total Liabilities BOY$26,153,882TotalLiabilitiesBOYAmt
Total Liabilities EOY$26,015,982TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY$40,485,091NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY$42,069,031NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part IIIYes (X)InfoInScheduleOPartIIIInd
MissionTHE BIOTECHNOLOGY INDUSTRY ORGANIZATION (BIO) REPRESENTS APPROXIMATELY 1,000 COMPANIES AND ORGANIZATIONS IN WASHINGTON DC, STATE CAPITALS, AND INTERNATIONAL FORA. BIO IS FOUNDED ON THE PRINCIPLE THAT POLICY MUST NURTURE INNOVATION IN THE LIFE SCIENCES TO OVERCOME CHALLENGES IN HEALTH CARE, AGRICULTURE, INDUSTRY, AND THE ENVIRONMENT. OUR MEMBERS REPRESENT COMPANIES OFFERING A SPECTRUM OF BIOTECHNOLOGY APPLICATIONS ACROSS MAJOR SECTORS OF THE ECONOMY. BIO MEMBERS ALSO INCLUDE UNIVERSITIES, NONPROFITS, PATIENT GROUPS, AND OTHER ORGANIZATIONS THAT PLAY AN IMPORTANT ROLE IN THE FUTURE OF THE LIFE SCIENCES. BIO'S ACTIVITIES ARE BROKEN DOWN INTO TWO PROGRAMS - ADVOCACY AND SERVICES.MissionDesc
Significant New Program Srvc0SignificantNewProgramSrvcInd
Significant Change0SignificantChangeInd
DescADVOCACYBIO'S ADVOCACY EFFORTS REFLECT THE PRIORITIES IDENTIFIED BY THE BIO BOARD OF DIRECTORS AND THE FOUR SECTION GOVERNING BOARDS.THE BOARD OF DIRECTORS FOCUSES ON ISSUES OF IMPORTANCE TO ALL BIO MEMBERS, REGARDLESS OF THEIR SIZE OR TECHNOLOGY. THESE CROSS-CUTTING ADVOCACY ACCOMPLISHMENTS IN 2014 ARE LISTED BELOW: - SAFEGUARDED AND ADVANCED INTELLECTUAL PROPERTY PROTECTIONS, DOMESTICALLY AND INTERNATIONALLY.- FOSTERED A DIALOGUE ABOUT ETHICS AND PROACTIVELY ADVANCED THE SOCIALLY RESPONSIBLE USE OF BIOTECHNOLOGY.- PROMOTED INVESTMENT IN GOVERNMENT AND ACADEMIC RESEARCH.- PROMOTED COMPREHENSIVE REFORM OF THE U.S. TAX CODE TO SPUR INNOVATION AND INVESTMENT IN BIOTECHNOLOGY.- EXPANDED OUTREACH TO FOREIGN GOVERNMENTS AND INTERNATIONAL ENTITIES TO EDUCATE ON POLICY ISSUES OF IMPORTANCE TO THE BIOTECHNOLOGY INDUSTRY AND TO IMPROVE THE INVESTMENT AND REGULATORY CLIMATE FOR BIOTECH PRODUCTS.THE HEALTH SECTION 2014 ADVOCACY ACCOMPLISHMENTS:- INFLUENCED IMPROVEMENTS TO THE U.S. FOOD AND DRUG ADMINISTRATION'S (FDA'S) PROCESS FOR HUMAN DRUG REVIEW.- ENHANCED AND PROTECTED PATIENT ACCESS TO INNOVATIVE THERAPIES.- ADVOCATED FOR BIOSIMILAR POLICIES THAT PROTECT PATIENT SAFETY AND PROMOTE BIOMEDICAL INNOVATION.- PROMOTED DEVELOPMENT AND USE OF RESEARCH TOOLS, MOLECULAR DIAGNOSTICS AND PERSONALIZED THERAPIES. - ADVOCATED FOR POLICIES THAT FOSTER VACCINE INNOVATION AND PROMOTE PANDEMIC AND BIO-DEFENSE PREPAREDNESS.- INFLUENCED IMPROVEMENTS TO THE INTERNATIONAL ENVIRONMENT FOR BIOMEDICAL INNOVATION.THE EMERGING COMPANIES SECTION 2014 ADVOCACY ACCOMPLISHMENTS: - ADVANCED THE INTEREST OF EMERGING COMPANIES IN HEALTH, REGULATORY, CAPITAL FORMATION, TAX, AND FINANCIAL SERVICES POLICY.- ADVOCATED FOR TAX POLICIES SUPPORTING INNOVATIVE EMERGING COMPANIES AND INVESTMENT IN GROUNDBREAKING R&D.- ADVOCATED FOR THE REMOVAL OF BURDENSOME FINANCIAL REPORTING REGULATIONS ON EMERGING COMPANIES, AND FOR ENHANCED FINANCIAL PATHWAYS TO CAPITAL FORMATION.- INFLUENCED BIO'S HEALTH CARE POLICIES TO REFLECT THE CONCERNS OF SMALL BIOTECHNOLOGY COMPANIES.THE FOOD & AGRICULTURE SECTION 2014 ADVOCACY ACCOMPLISHMENTS: - WORKED WITH THE ADMINISTRATION AND CONGRESS TO ADVANCE IMPROVEMENTS TO THE U.S. AND GLOBAL REGULATORY SYSTEMS IN AN EFFORT TO PROVIDE PREDICTABILITY IN REGULATORY DECISIONS. - WORKED WITH MEMBERS OF THE AGRICULTURAL VALUE CHAIN, LARGELY THROUGH THE U.S. BIOTECH CROPS ALLIANCE (USBCA), TO ADDRESS TRADE ISSUES IN AGRICULTURAL EXPORT MARKETS SUCH AS CHINA AND EUROPE. - FOSTERED A DIALOGUE WITH CONSUMERS AIMED AT ADDRESSING CONCERNS ABOUT GMOS. - PARTICIPATED IN THE LAUNCH OF THE COALITION FOR SAFE AFFORDABLE FOOD, AN ALLIANCE OF OVER 30 MEMBERS FROM ACROSS THE SUPPLY CHAIN, TO ADVANCE FEDERAL GMO FOOD LABELING UNIFORMITY. - WORKED WITH AGRICULTURAL INDUSTRY ALLIES TO OPPOSE FEDERAL AND STATE-LEVEL INITIATIVES AIMED AT MANDATING GMO FOOD LABELING.- MOUNTED LEGAL CHALLENGES TO PRESERVE THE RIGHTS OF FARMERS TO PLANT GENETICALLY ENGINEERED CROPS.THE INDUSTRIAL & ENVIRONMENTAL SECTION 2014 ADVOCACY ACCOMPLISHMENTS: - SUCCESSFULLY ADVOCATED FOR CONGRESS TO PRESERVE THE RENEWABLE FUELS STANDARD.- WORKED TO ENSURE THE APPROPRIATE IMPLEMENTATION OF THE FEDERAL FARM BILL LEGISLATION AND TO ENSURE KEY PROVISIONS WERE EXTENDED TO RENEWABLE CHEMICALS. - SUCCESSFULLY ADVOCATED FOR FUNDING OF THE NAVY GREEN FLEET INITIATIVE AND DEFENSE BIOFUELS MOU.Desc

Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp

FieldValueIRS element (for citing)
DescSERVICESBIO'S SERVICES INCLUDE CONFERENCES AND ACTIVITIES THAT BRING TOGETHER INDUSTRY PARTNERS AND INVESTORS FOR EVENTS RANGING FROM THE BIO INTERNATIONAL CONVENTION TO CONFERENCES FOR BUSINESS DEVELOPMENT EXECUTIVES. THE BIO INTERNATIONAL CONVENTION ATTRACTS OVER 15,000 OF THE MOST INFLUENTIAL BIOTECH AND PHARMA ATTENDEES FROM 65 COUNTRIES AND 49 U.S. STATES, INCLUDING 300 MEMBERS OF THE MEDIA, AND OFFERS THREE DAYS OF PROFESSIONAL AND BUSINESS DEVELOPMENT OPPORTUNITIES. THE NET INCOME FROM THE CONVENTION SUPPORTS OUR ADVOCACY, PUBLIC OUTREACH, AND OTHER MEMBER SERVICE ACTIVITIES.THE KEY ELEMENTS OF THE BIO INTERNATIONAL CONVENTION ARE EDUCATIONAL PROGRAMMING, EXHIBITION, THE BIO BUSINESS FORUM, AND NETWORKING EVENTS. THESE ELEMENTS PROVIDE AN OPPORTUNITY FOR BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, ACADEMIC RESEARCH INSTITUTIONS, AND INVESTORS FROM AROUND THE WORLD TO LEARN ABOUT RECENT SCIENTIFIC AND POLICY DEVELOPMENTS, AND SCHEDULE ONE-ON-ONE MEETINGS TO DISCUSS POTENTIAL BUSINESS OPPORTUNITIES. IN 2014, THE BIO BUSINESS FORUM ALONE HELPED HOST A RECORD NUMBER OF OVER 27,000 PARTNERING MEETINGS AMONG MORE THAN 2,000 COMPANIES, ALONG WITH SOME 150 COMPANY PRESENTATIONS.BEYOND THE CONVENTION, BIO HOSTS OR CO-HOSTS A NUMBER OF NATIONAL AND INTERNATIONAL CONFERENCES THAT PROVIDE VENUES FOR MEMBER AND NON-MEMBER COMPANIES TO PRESENT NEW DATA, MEET AND PARTNER WITH FELLOW BIOTECH COMPANIES, AND ATTRACT FUNDING FROM INVESTORS AND OTHER ORGANIZATIONS.Desc
FieldValueIRS element (for citing)
Described In Section501c30DescribedInSection501c3Ind
Schedule B Required0ScheduleBRequiredInd
Political Campaign ActyYes (1)PoliticalCampaignActyInd
Subject To Proxy TaxYes (1)SubjectToProxyTaxInd
Donor Advised Fund0DonorAdvisedFundInd
Conservation Easements0ConservationEasementsInd
Collections Of Art0CollectionsOfArtInd
Credit Counseling0CreditCounselingInd
Temp Or Permanent Endowments0TempOrPermanentEndowmentsInd
Report Land Building EquipmentYes (1)ReportLandBuildingEquipmentInd
Report Investments Other Sec0ReportInvestmentsOtherSecInd
Report Program Related Invst0ReportProgramRelatedInvstInd
Report Other Assets0ReportOtherAssetsInd
Report Other LiabilitiesYes (1)ReportOtherLiabilitiesInd
Include FIN48 Footnote0IncludeFIN48FootnoteInd
Independent Audit Fincl StmtYes (1)IndependentAuditFinclStmtInd
Consolidated Audit Fincl Stmt0ConsolidatedAuditFinclStmtInd
School Operating0SchoolOperatingInd
Foreign Office0ForeignOfficeInd
Foreign ActivitiesYes (1)ForeignActivitiesInd
More Than5000 K To Org0MoreThan5000KToOrgInd
More Than5000 K To Individuals0MoreThan5000KToIndividualsInd
Professional Fundraising0ProfessionalFundraisingInd
Fundraising Activities0FundraisingActivitiesInd
Gaming Activities0GamingActivitiesInd
Operate Hospital0OperateHospitalInd
Grants To OrganizationsYes (1)GrantsToOrganizationsInd
Grants To Individuals0GrantsToIndividualsInd
Schedule J RequiredYes (1)ScheduleJRequiredInd
Tax Exempt Bonds0TaxExemptBondsInd
Loan Outstanding0LoanOutstandingInd
Grant To Related Person0GrantToRelatedPersonInd
Business Rln With Org Mem0BusinessRlnWithOrgMemInd
Business Rln With Fam Mem0BusinessRlnWithFamMemInd
Business Rln With Officer Ent0BusinessRlnWithOfficerEntInd
Deductible Non Cash Contri0DeductibleNonCashContriInd
Deductible Art Contribution0DeductibleArtContributionInd
Terminate Operations0TerminateOperationsInd
Partial Liquidation0PartialLiquidationInd
Disregarded Entity0DisregardedEntityInd
Related Entity0RelatedEntityInd
Related Organization Ctrl Ent0RelatedOrganizationCtrlEntInd
Activities Conducted Prtshp0ActivitiesConductedPrtshpInd
Schedule O RequiredYes (1)ScheduleORequiredInd
IRP Document155IRPDocumentCnt
IRP Document W2 G0IRPDocumentW2GCnt
Employee190EmployeeCnt
Employment Tax Returns FiledYes (1)EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over LimitYes (1)UnrelatedBusIncmOverLimitInd
Form990 T FiledYes (1)Form990TFiledInd
Foreign Financial AccountYes (1)ForeignFinancialAccountInd
Foreign CountryINForeignCountryCd
Prohibited Tax Shelter Trans0ProhibitedTaxShelterTransInd
Taxable Party Notification0TaxablePartyNotificationInd
Nondeductible Contributions0NondeductibleContributionsInd
Indoor Tanning Services0IndoorTanningServicesInd
Info In Schedule O Part VIYes (X)InfoInScheduleOPartVIInd
Governing Body Voting Members107GoverningBodyVotingMembersCnt
Independent Voting Member107IndependentVotingMemberCnt
Family Or Business RlnYes (1)FamilyOrBusinessRlnInd
Delegation Of Mgmt Duties0DelegationOfMgmtDutiesInd
Change To Org DocumentsYes (1)ChangeToOrgDocumentsInd
Material Diversion Or Misuse0MaterialDiversionOrMisuseInd
Members Or StockholdersYes (1)MembersOrStockholdersInd
Election Of Board MembersYes (1)ElectionOfBoardMembersInd
Decisions Subject To Approva0DecisionsSubjectToApprovaInd
Minutes Of Governing BodyYes (1)MinutesOfGoverningBodyInd
Minutes Of CommitteesYes (1)MinutesOfCommitteesInd
Officer Mailing Address0OfficerMailingAddressInd
Local Chapters0LocalChaptersInd
Form990 Provided To Gvrn BodyYes (1)Form990ProvidedToGvrnBodyInd
Conflict Of Interest PolicyYes (1)ConflictOfInterestPolicyInd
Annual Disclosure Covered PrsnYes (1)AnnualDisclosureCoveredPrsnInd
Regular Monitoring EnfrcYes (1)RegularMonitoringEnfrcInd
Whistleblower PolicyYes (1)WhistleblowerPolicyInd
Document Retention PolicyYes (1)DocumentRetentionPolicyInd
Compensation Process CEOYes (1)CompensationProcessCEOInd
Compensation Process Other0CompensationProcessOtherInd
Investment In Joint Venture0InvestmentInJointVentureInd
Upon RequestYes (X)UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

FieldValueIRS element (for citing)
PersonJOANNE M DUNCANPersonNm
Phone2029629200PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line11201 MARYLAND AVENUE SW NO 900AddressLine1Txt
CityWASHINGTONCityNm
State AbbreviationDCStateAbbreviationCd
ZIP20024ZIPCd

Form990 Part VII Section A Form990PartVIISectionAGrp (152 entries)

TitleTitleTxtAverage Hours Per WeekAverageHoursPerWeekRtIndividual Trustee Or DirectorIndividualTrusteeOrDirectorIndOfficerOfficerIndReportable Comp From OrgReportableCompFromOrgAmtReportable Comp From Rltd OrgReportableCompFromRltdOrgAmtOther CompensationOtherCompensationAmtKey EmployeeKeyEmployeeIndHighest Compensated EmployeeHighestCompensatedEmployeeInd
ADAM MONROE
VICE CHAIR FOR INDUSTRIAL & ENVIRONMENTAL2.00Yes (X)Yes (X)$0$0$0
ADELENE PERKINS
MEMBER2.00Yes (X)$0$0$0
ADRIAN ADAMS
MEMBER2.00Yes (X)$0$0$0
ALEX AZAR
MEMBER2.00Yes (X)$0$0$0
ALEXIS BORISY
MEMBER2.00Yes (X)$0$0$0
ALLEN WAXMAN
MEMBER2.00Yes (X)$0$0$0
ANDREW HINDMAN
MEMBER2.00Yes (X)$0$0$0
ANNA PROTOPAPAS
MEMBER2.00Yes (X)$0$0$0
ANNA RATH
MEMBER2.00Yes (X)$0$0$0
ANNALISA JENKINS
MEMBER2.00Yes (X)$0$0$0
ARLENE MORRIS
MEMBER2.00Yes (X)$0$0$0
ARTHUR SANDS
MEMBER2.00Yes (X)$0$0$0
ATUL THAKRAR
MEMBER2.00Yes (X)$0$0$0
BARBARA KOSACZ
MEMBER2.00Yes (X)$0$0$0
WILLIAM LIS
MEMBER2.00Yes (X)$0$0$0
BRADFORD ZAKES
MEMBER2.00Yes (X)$0$0$0
BRADLEY SHURDUT
MEMBER2.00Yes (X)$0$0$0
BRIAN ATWOOD
MEMBER2.00Yes (X)$0$0$0
CARLOS PAYA
MEMBER2.00Yes (X)$0$0$0
CENAN OZMERAL
MEMBER2.00Yes (X)$0$0$0
CHARLES EGGERT
MEMBER2.00Yes (X)$0$0$0
CHRISTI SHAW
MEMBER2.00Yes (X)$0$0$0
CHRISTIAN NOLET
MEMBER2.00Yes (X)$0$0$0
CHRISTOPHER STANDLEE
MEMBER2.00Yes (X)$0$0$0
DANIEL APEL
MEMBER2.00Yes (X)$0$0$0
DANIEL CUMMINGS
MEMBER2.00Yes (X)$0$0$0
DANIEL JUNIUS
TREASURER2.00Yes (X)Yes (X)$0$0$0
DANIEL TASSE
MEMBER2.00Yes (X)$0$0$0
DAPHNE PREUSS
MEMBER2.00Yes (X)$0$0$0
DAVID PYOTT
SECRETARY2.00Yes (X)Yes (X)$0$0$0
DAVID STACK
MEMBER2.00Yes (X)$0$0$0
DAVID MAIN
MEMBER2.00Yes (X)$0$0$0
DAVID MEEKER
MEMBER2.00Yes (X)$0$0$0
DAVID SCHENKEIN
MEMBER2.00Yes (X)$0$0$0
DEBORAH DUNSIRE
MEMBER2.00Yes (X)$0$0$0
DOUG BERVEN
MEMBER2.00Yes (X)$0$0$0
DOUGLAS DOERFLER
MEMBER2.00Yes (X)$0$0$0
EDDIE SULLIVAN
MEMBER2.00Yes (X)$0$0$0
EDWARD MATHERS
MEMBER2.00Yes (X)$0$0$0
EMER LEAHY
MEMBER2.00Yes (X)$0$0$0
FAHEEM HASNAIN
MEMBER2.00Yes (X)$0$0$0
FLEMMING ORNSKOV
MEMBER2.00Yes (X)$0$0$0
FRANCOIS NADER
MEMBER2.00Yes (X)$0$0$0
FRANK TERHORST
MEMBER2.00Yes (X)$0$0$0
FRANK VERWIEL
MEMBER2.00Yes (X)$0$0$0
GENO GERMANO
MEMBER2.00Yes (X)$0$0$0
GERALD STEINER
MEMBER2.00Yes (X)$0$0$0
GIL VAN BOKKELEN
MEMBER2.00Yes (X)$0$0$0
GLEN GIOVANNETTI
MEMBER2.00Yes (X)$0$0$0
GLENN GORMLEY
MEMBER2.00Yes (X)$0$0$0
GORDON MCCAULEY
MEMBER2.00Yes (X)$0$0$0
H THOMAS WATKINS
MEMBER2.00Yes (X)$0$0$0
HANS SCHIKAN
MEMBER2.00Yes (X)$0$0$0
HAROLD VAN WART
MEMBER2.00Yes (X)$0$0$0
HENRI TERMEER
MEMBER2.00Yes (X)$0$0$0
HERVE HOPPENOT
MEMBER2.00Yes (X)$0$0$0
HOWARD ROBIN
MEMBER2.00Yes (X)$0$0$0
IAN CLARK
MEMBER2.00Yes (X)$0$0$0
JAMES LEVINE
MEMBER2.00Yes (X)$0$0$0
JAY SIEGEL
MEMBER2.00Yes (X)$0$0$0
JEAN-FRANCOIS FORMELA
MEMBER2.00Yes (X)$0$0$0
JEAN-JACQUES BIENAIME
MEMBER2.00Yes (X)$0$0$0
JEFFREY HANKE
MEMBER2.00Yes (X)$0$0$0
JEFFREY OSTROVE
MEMBER2.00Yes (X)$0$0$0
JEFFREY HATFIELD
MEMBER2.00Yes (X)$0$0$0
JEFFREY WREN
MEMBER2.00Yes (X)$0$0$0
JERRY FLINT
VICE CHAIR FOR FOOD & AGRICULTURE2.00Yes (X)Yes (X)$0$0$0
JOHN ORWIN
MEMBER2.00Yes (X)$0$0$0
JOHN CROWLEY
MEMBER2.00Yes (X)$0$0$0
JOHN MILLIGAN
MEMBER2.00Yes (X)$0$0$0
JOHN JOHNSON
MEMBER2.00Yes (X)$0$0$0
JOHN NICOLS
MEMBER2.00Yes (X)$0$0$0
JOHN MARAGANORE
VICE CHAIR FOR EMERGING COMPANIES2.00Yes (X)Yes (X)$0$0$0
JOHN MENDLEIN
MEMBER2.00Yes (X)$0$0$0
JOHN SWART
MEMBER2.00Yes (X)$0$0$0
JONATHAN LEFF
MEMBER2.00Yes (X)$0$0$0
JONATHAN PEACOCK
MEMBER2.00Yes (X)$0$0$0
JONATHAN WOLFSON
MEMBER2.00Yes (X)$0$0$0
JOSEPH SHAULSON
MEMBER2.00Yes (X)$0$0$0
JULIE GERBERDING
MEMBER2.00Yes (X)$0$0$0
KENNETH MOCH
MEMBER2.00Yes (X)$0$0$0
KLAUS WILGENBUS
MEMBER2.00Yes (X)$0$0$0
KLEANTHIS XANTHOPOULOS
MEMBER2.00Yes (X)$0$0$0
KRISTINE PETERSON
MEMBER2.00Yes (X)$0$0$0
LAURA SCHUMACHER
MEMBER2.00Yes (X)$0$0$0
LUDWIG HANTSON
MEMBER2.00Yes (X)$0$0$0
MARC BEER
MEMBER2.00Yes (X)$0$0$0
MARC VERBRUGGEN
MEMBER2.00Yes (X)$0$0$0
MARK JONES
MEMBER2.00Yes (X)$0$0$0
MARK PRUZANSKI
MEMBER2.00Yes (X)$0$0$0
MARK SKALETSKY
MEMBER2.00Yes (X)$0$0$0
MARK TIMNEY
MEMBER2.00Yes (X)$0$0$0
MARK WONG
MEMBER2.00Yes (X)$0$0$0
MARKUS POMPEJUS
MEMBER2.00Yes (X)$0$0$0
MARTIN BABLER
MEMBER2.00Yes (X)$0$0$0
MATTHIAS MEDER
MEMBER2.00Yes (X)$0$0$0
MAXINE GOWEN
MEMBER2.00Yes (X)$0$0$0
MICHAEL NARACHI
MEMBER2.00Yes (X)$0$0$0
MICHAEL SEVERINO
MEMBER2.00Yes (X)$0$0$0
MICHELLE DIPP
MEMBER2.00Yes (X)$0$0$0
MONCEF SLAOUI
MEMBER2.00Yes (X)$0$0$0
NEAL GUTTERSON
MEMBER2.00Yes (X)$0$0$0
NEIL WARMA
MEMBER2.00Yes (X)$0$0$0
NICK LESCHLY
MEMBER2.00Yes (X)$0$0$0
PARIS PANAYIOTOPOULOS
MEMBER2.00Yes (X)$0$0$0
PATRICK GRUBER
MEMBER2.00Yes (X)$0$0$0
PAUL HUDSWON
MEMBER2.00Yes (X)$0$0$0
PAUL HASTINGS
MEMBER2.00Yes (X)$0$0$0
PAUL EISENBERG
MEMBER2.00Yes (X)$0$0$0
PERRY KARSEN
MEMBER2.00Yes (X)$0$0$0
PETER GREENLEAF
MEMBER2.00Yes (X)$0$0$0
PHILIP MILLER
MEMBER2.00Yes (X)$0$0$0
R JOHN GLASSPOOL
MEMBER2.00Yes (X)$0$0$0
RACHEL KING
BOARD CHAIR2.00Yes (X)Yes (X)$0$0$0
RAYMOND SACCHETTI
MEMBER2.00Yes (X)$0$0$0
RICHARD ENO
MEMBER2.00Yes (X)$0$0$0
RICHARD POPS
MEMBER2.00Yes (X)$0$0$0
RICK WINNINGHAM
MEMBER2.00Yes (X)$0$0$0
ROBERT KISS
MEMBER2.00Yes (X)$0$0$0
ROBERT BEALL
MEMBER2.00Yes (X)$0$0$0
ROBIN READNOUR
MEMBER2.00Yes (X)$0$0$0
ROCH DOLIVEUS
MEMBER2.00Yes (X)$0$0$0
RON COHEN
VICE CHAIR FOR HEALTHCARE2.00Yes (X)Yes (X)$0$0$0
RONALD STOTISH
MEMBER2.00Yes (X)$0$0$0
RUSSELL HERNDON
MEMBER2.00Yes (X)$0$0$0
RUSSELL MEDFORD
MEMBER2.00Yes (X)$0$0$0
SCOTT KOENIG
MEMBER2.00Yes (X)$0$0$0
STANLEY CROOKE
MEMBER2.00Yes (X)$0$0$0
STEPHAN TANDA
MEMBER2.00Yes (X)$0$0$0
STEPHEN SHERWIN
MEMBER2.00Yes (X)$0$0$0
STEVEN HOLTZMAN
MEMBER2.00Yes (X)$0$0$0
STEVEN MENTO
MEMBER2.00Yes (X)$0$0$0
STUART ARBUCKLE
MEMBER2.00Yes (X)$0$0$0
STUART PELTZ
MEMBER2.00Yes (X)$0$0$0
THOMAS MATHERS
MEMBER2.00Yes (X)$0$0$0
THOMAS TAYLOR
MEMBER2.00Yes (X)$0$0$0
TIMOTHY RODELL
MEMBER2.00Yes (X)$0$0$0
TIMOTHY WALBERT
MEMBER2.00Yes (X)$0$0$0
VINCENT MILANO
MEMBER2.00Yes (X)$0$0$0
WILLIAM FEEHERY
MEMBER2.00Yes (X)$0$0$0
WILLIAM FITZSIMMONS
MEMBER2.00Yes (X)$0$0$0
JAMES GREENWOOD
CEO & PRESIDENT40.00Yes (X)$3,286,030$0$41,019
JOANNE DUNCAN
CFO & SVP, FINANCE & ADMIN40.00Yes (X)$424,879$0$60,357
A SCOTT WHITAKER
COO40.00$802,829$0$146,323Yes (X)
THOMAS DILENGE
GENERAL COUNSEL & HEAD OF PUBLIC POLICY40.00$555,272$0$58,924Yes (X)
FREDERICK BITTENBENDER
EVP, PUBLIC AFFAIRS40.00$512,287$0$56,261Yes (X)
AMY FINAN
SVP, BUSINESS DEVELOPMENT40.00$420,340$0$46,342Yes (X)
BRENT ERICKSON
EVP, INDUSTRIAL & ENVIRONMENTAL40.00$474,825$0$48,449Yes (X)
CARTIER ESHAM
EVP, EMERGING COMPANIES40.00$386,937$0$42,967Yes (X)
JOSEPH DAMOND
SVP, INTERNATIONAL AFFAIRS40.00$440,824$0$59,479Yes (X)
BRENT DELMONTE
SVP, FEDERAL GOVERNMENT RELATIONS40.00$515,641$0$46,827Yes (X)
SARA RADCLIFFE
SVP, HEALTH40.00$493,752$0$53,174Yes (X)
FieldValueIRS element (for citing)
Total Reportable Comp From Org$8,313,616TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org$0TotReportableCompRltdOrgAmt
Total Other Compensation$660,122TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K78IndivRcvdGreaterThan100KCnt
Former Ofcr Employees Listed0FormerOfcrEmployeesListedInd
Total Comp Greater Than150 KYes (1)TotalCompGreaterThan150KInd
Compensation From Other Srcs0CompensationFromOtherSrcsInd

Contractor Compensation ContractorCompensationGrp (5 entries)

Address Line1ContractorAddress/USAddress/AddressLine1TxtCityContractorAddress/USAddress/CityNmState AbbreviationContractorAddress/USAddress/StateAbbreviationCdZIPContractorAddress/USAddress/ZIPCdServicesServicesDescCompensationCompensationAmt
FREEMAN EXPOSITIONS
PO BOX 660613DALLASTX75266CONVENTION & CONFERENCES GENERAL CONTRAC$2,010,932
ARENT FOX
1717 K STREET NWWASHINGTONDC20036LEGAL CONSULTING SERVICES$1,250,778
PROJECTION INC
PO BOX 890472CHARLOTTENC28289VIDEO SERVICES FOR CONVENTION & CONFEREN$830,454
PERSONIFY INC
1919 GALLOWS ROAD SUITE 400VIENNAVA22182AMS AND DATABASE MAINTENANCE SERVICES$795,181
CENTERPLATE
111 W HARBOR DRIVESAN DIEGOCA92101CATERING FOR INTERNATIONAL CONVENTION$781,179
FieldValueIRS element (for citing)
Cntrct Rcvd Greater Than100 K80CntrctRcvdGreaterThan100KCnt

Program Service Revenue ProgramServiceRevenueGrp (3 entries)

DescDescBusinessBusinessCdTotal Revenue ColumnTotalRevenueColumnAmtRelated Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmtUnrelated Business RevenueUnrelatedBusinessRevenueAmt
CONFERENCE/MEETING REVENUE541800$33,848,757$33,553,282$295,475
MEMBERSHIP DUES900099$25,095,274$25,095,274
PUBLICATION ADVERTISING541800$42,000$42,000
FieldValueIRS element (for citing)
Total Program Service Revenue$58,986,031TotalProgramServiceRevenueAmt

Investment Income InvestmentIncomeGrp

FieldValueIRS element (for citing)
Total Revenue Column$1,497,565TotalRevenueColumnAmt
Exclusion$1,497,565ExclusionAmt

Royalties Revenue RoyaltiesRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$4,758,428TotalRevenueColumnAmt
Exclusion$4,758,428ExclusionAmt

Gross Rents GrossRentsGrp

FieldValueIRS element (for citing)
Real$45,050RealAmt

Less Rental Expenses LessRentalExpensesGrp

FieldValueIRS element (for citing)
Real$45,050RealAmt

Rental Income Or Loss RentalIncomeOrLossGrp

FieldValueIRS element (for citing)
Real$0RealAmt

Gross Amount Sales Assets GrossAmountSalesAssetsGrp

FieldValueIRS element (for citing)
Securities$31,642,944SecuritiesAmt

Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp

FieldValueIRS element (for citing)
Securities$30,105,450SecuritiesAmt

Gain Or Loss GainOrLossGrp

FieldValueIRS element (for citing)
Securities$1,537,494SecuritiesAmt

Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp

FieldValueIRS element (for citing)
Total Revenue Column$1,537,494TotalRevenueColumnAmt
Exclusion$1,537,494ExclusionAmt

Other Revenue Misc OtherRevenueMiscGrp (2 entries)

DescDescBusinessBusinessCdTotal Revenue ColumnTotalRevenueColumnAmtUnrelated Business RevenueUnrelatedBusinessRevenueAmtExclusionExclusionAmt
JOB BOARD REVENUE900099$36,705$36,705
MISCELLANEOUS REVENUE900099$1,076$1,076
FieldValueIRS element (for citing)
Other Revenue Total$37,781OtherRevenueTotalAmt

Total Revenue TotalRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$66,817,299TotalRevenueColumnAmt
Related Or Exempt Func Income$58,648,556RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$374,180UnrelatedBusinessRevenueAmt
Exclusion$7,794,563ExclusionAmt

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

FieldValueIRS element (for citing)
Total$588,500TotalAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

FieldValueIRS element (for citing)
Total$6,410,863TotalAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

FieldValueIRS element (for citing)
Total$18,407,277TotalAmt

Pension Plan Contributions PensionPlanContributionsGrp

FieldValueIRS element (for citing)
Total$1,827,001TotalAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

FieldValueIRS element (for citing)
Total$2,779,797TotalAmt

Payroll Taxes PayrollTaxesGrp

FieldValueIRS element (for citing)
Total$901,709TotalAmt

Fees For Services Legal FeesForServicesLegalGrp

FieldValueIRS element (for citing)
Total$269,942TotalAmt

Fees For Services Accounting FeesForServicesAccountingGrp

FieldValueIRS element (for citing)
Total$60,954TotalAmt

Fees For Services Lobbying FeesForServicesLobbyingGrp

FieldValueIRS element (for citing)
Total$1,504,000TotalAmt

Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp

FieldValueIRS element (for citing)
Total$373,202TotalAmt

Fees For Services Other FeesForServicesOtherGrp

FieldValueIRS element (for citing)
Total$6,024,886TotalAmt

Advertising AdvertisingGrp

FieldValueIRS element (for citing)
Total$175,859TotalAmt

Office Expenses OfficeExpensesGrp

FieldValueIRS element (for citing)
Total$1,624,006TotalAmt

Information Technology InformationTechnologyGrp

FieldValueIRS element (for citing)
Total$824,224TotalAmt

Occupancy OccupancyGrp

FieldValueIRS element (for citing)
Total$4,101,466TotalAmt

Travel TravelGrp

FieldValueIRS element (for citing)
Total$1,237,587TotalAmt

Conferences Meetings ConferencesMeetingsGrp

FieldValueIRS element (for citing)
Total$15,999,856TotalAmt

Interest InterestGrp

FieldValueIRS element (for citing)
Total$2,206TotalAmt

Payments To Affiliates PaymentsToAffiliatesGrp

FieldValueIRS element (for citing)
Total$1,916,141TotalAmt

Depreciation Depletion DepreciationDepletionGrp

FieldValueIRS element (for citing)
Total$804,146TotalAmt

Insurance InsuranceGrp

FieldValueIRS element (for citing)
Total$119,758TotalAmt

Other Expenses OtherExpensesGrp (4 entries)

DescDescTotalTotalAmt
TAXES PAID$75,126
EDUCATION$30,842
BAD DEBT EXPENSE$26,760
OUTREACH$3,166

All Other Expenses AllOtherExpensesGrp

FieldValueIRS element (for citing)
Total$43,690TotalAmt

Total Functional Expenses TotalFunctionalExpensesGrp

FieldValueIRS element (for citing)
Total$66,132,964TotalAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

FieldValueIRS element (for citing)
BOY$1,370,438BOYAmt
EOY$2,183,816EOYAmt

Accounts Receivable AccountsReceivableGrp

FieldValueIRS element (for citing)
BOY$2,836,623BOYAmt
EOY$2,694,981EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

FieldValueIRS element (for citing)
BOY$1,511,943BOYAmt
EOY$1,857,354EOYAmt
FieldValueIRS element (for citing)
Land Bldg Equip Cost Or Other Bss$10,766,570LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec$8,467,276LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

FieldValueIRS element (for citing)
BOY$2,506,902BOYAmt
EOY$2,299,294EOYAmt

Investments Pub Traded Sec InvestmentsPubTradedSecGrp

FieldValueIRS element (for citing)
BOY$58,266,627BOYAmt
EOY$58,908,990EOYAmt

Other Assets Total OtherAssetsTotalGrp

FieldValueIRS element (for citing)
BOY$146,440BOYAmt
EOY$140,578EOYAmt

Total Assets TotalAssetsGrp

FieldValueIRS element (for citing)
BOY$66,638,973BOYAmt
EOY$68,085,013EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

FieldValueIRS element (for citing)
BOY$11,686,388BOYAmt
EOY$11,562,927EOYAmt

Deferred Revenue DeferredRevenueGrp

FieldValueIRS element (for citing)
BOY$8,913,117BOYAmt
EOY$9,132,296EOYAmt

Other Liabilities OtherLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$5,554,377BOYAmt
EOY$5,320,759EOYAmt

Total Liabilities TotalLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$26,153,882BOYAmt
EOY$26,015,982EOYAmt
FieldValueIRS element (for citing)
Organization Follows SFAS117Yes (X)OrganizationFollowsSFAS117Ind

Unrestricted Net Assets UnrestrictedNetAssetsGrp

FieldValueIRS element (for citing)
BOY$40,485,091BOYAmt
EOY$42,069,031EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$40,485,091BOYAmt
EOY$42,069,031EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$66,638,973BOYAmt
EOY$68,085,013EOYAmt
FieldValueIRS element (for citing)
Info In Schedule O Part XIYes (X)InfoInScheduleOPartXIInd
Reconcilation Revenue Expnss$684,335ReconcilationRevenueExpnssAmt
Net Unrlzd Gains Losses Invst$859,118NetUnrlzdGainsLossesInvstAmt
Other Changes In Net Assets$40,487OtherChangesInNetAssetsAmt
Method Of Accounting AccrualYes (X)MethodOfAccountingAccrualInd
Accountant Compile Or Review0AccountantCompileOrReviewInd
FS AuditedYes (1)FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

FieldValueIRS element (for citing)
Separate Basis Fincl StmtYes (X)SeparateBasisFinclStmtInd
FieldValueIRS element (for citing)
Audit CommitteeYes (1)AuditCommitteeInd
Federal Grant Audit Required0FederalGrantAuditRequiredInd

Schedule C IRS990ScheduleC

FieldValueIRS element (for citing)
Political Expenditures$5,000PoliticalExpendituresAmt
Volunteer Hours0VolunteerHoursCnt
Expended527 Activities$5,000Expended527ActivitiesAmt
Internal Funds Contributed$0InternalFundsContributedAmt
Total Exempt Function Expend$5,000TotalExemptFunctionExpendAmt
Form1120 POL FiledYes (1)Form1120POLFiledInd

Section527 Political Org Section527PoliticalOrgGrp

Organization Business Name OrganizationBusinessName

FieldValueIRS element (for citing)
Business Name Line1NEWSOM FOR CALIFORNIA LIETUENANT GOVERNORBusinessNameLine1Txt

US Address USAddress

FieldValueIRS element (for citing)
Address Line19869 EASTON DRAddressLine1Txt
CityBEVERLY HILLSCityNm
State AbbreviationCAStateAbbreviationCd
ZIP90210ZIPCd
FieldValueIRS element (for citing)
EIN273872296EIN
Paid Internal Funds$5,000PaidInternalFundsAmt
Contributions Rcvd Dlvr$0ContributionsRcvdDlvrAmt
FieldValueIRS element (for citing)
Substantially All Dues Nonded0SubstantiallyAllDuesNondedInd
Only In House Lobbying0OnlyInHouseLobbyingInd
Agree Carryover Prior YearYes (1)AgreeCarryoverPriorYearInd
Dues Assessments$25,095,274DuesAssessmentsAmt
Non Deductible Lbbyng Pltcl CY$7,865,953NonDeductibleLbbyngPltclCYAmt
Non Ded Lbbyng Pltcl Cyov$33,386NonDedLbbyngPltclCyovAmt
Non Deductible Lbbyng Pltcl Tot$7,899,339NonDeductibleLbbyngPltclTotAmt
Aggregate Reported Dues Ntc$8,281,440AggregateReportedDuesNtcAmt
Taxable-$382,101TaxableAmt

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePART I-A, LINE 1:FormAndLineReferenceDesc
ExplanationBIO'S ONLY 2014 DIRECT POLITICAL CAMPAIGN ACTIVITY WAS A $5,000 CONTRIBUTION MADE TO NEWSOM FOR CALIFORNIA LIEUTENANT GOVERNOR. BIO DID NOT HAVE ANY INDIRECT POLITICAL CAMPAIGN ACTIVITY IN 2014.ExplanationTxt

Schedule D IRS990ScheduleD

Leasehold Improvements LeaseholdImprovementsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$5,988,846OtherCostOrOtherBasisAmt
Depreciation$4,262,345DepreciationAmt
Book Value$1,726,501BookValueAmt

Equipment EquipmentGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$1,967,376OtherCostOrOtherBasisAmt
Depreciation$1,817,242DepreciationAmt
Book Value$150,134BookValueAmt

Other Land Buildings OtherLandBuildingsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$2,810,348OtherCostOrOtherBasisAmt
Depreciation$2,387,689DepreciationAmt
Book Value$422,659BookValueAmt
FieldValueIRS element (for citing)
Total Book Value Land Buildings$2,299,294TotalBookValueLandBuildingsAmt

Other Liabilities Org OtherLiabilitiesOrgGrp (2 entries)

DescDescAmtAmt
CAPITAL LEASE OBLIGATION$150,349
DEFERRED RENT$5,170,410
FieldValueIRS element (for citing)
Total Liability$5,320,759TotalLiabilityAmt
Total Rev Etc Audited Fincl Stmt$69,879,469TotalRevEtcAuditedFinclStmtAmt
Net Unrealized Gains Invst$859,118NetUnrealizedGainsInvstAmt
Other Revenue$2,576,254OtherRevenueAmt
Revenue Not Reported$3,435,372RevenueNotReportedAmt
Revenue Subtotal$66,444,097RevenueSubtotalAmt
Investment Expenses Not Incld$373,202InvestmentExpensesNotIncldAmt
Revenue Not Reported Fincl Stmt$373,202RevenueNotReportedFinclStmtAmt
Total Revenue Per Form990$66,817,299TotalRevenuePerForm990Amt
Tot Expns Etc Audited Fincl Stmt$68,295,529TotExpnsEtcAuditedFinclStmtAmt
Other Expenses Included$2,535,767OtherExpensesIncludedAmt
Expenses Not Reported$2,535,767ExpensesNotReportedAmt
Expenses Subtotal$65,759,762ExpensesSubtotalAmt
Investment Expenses Not Incld2$373,202InvestmentExpensesNotIncld2Amt
Expenses Not Rpt Fincl Stmt$373,202ExpensesNotRptFinclStmtAmt
Total Expenses Per Form990$66,132,964TotalExpensesPerForm990Amt

Supplemental Information Detail SupplementalInformationDetail (2 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
PART XI, LINE 2D - OTHER ADJUSTMENTS:CBI LOBBYING FUND 856,950. FOOD & AG INITIATIVES REVENUE 32,064. FOOD & AG LEGAL FUND 1,218,240. BIOSIMILARS REVENUE 469,000.
PART XII, LINE 2D - OTHER ADJUSTMENTS:CBI LOBBYING FUND 828,095. FOOD & AG INITIATIVES REVENUE 32,064. FOOD & AG LEGAL FUND 1,218,240. BIOSIMILAR EXPENSES 457,368.

Schedule F IRS990ScheduleF

Account Activities Outside US AccountActivitiesOutsideUSGrp (5 entries)

RegionRegionTxtOfficesOfficesCntEmployeeEmployeeCntType Of Activities ConductedTypeOfActivitiesConductedTxtSpecific Services ProvidedSpecificServicesProvidedTxtRegion Total ExpendituresRegionTotalExpendituresAmt
EUROPE (INCLUDING ICELAND & GREENLAND)02PROGRAM SERVICESCONFERENCES AND ADVOCACY$286,103
SOUTH ASIA01PROGRAM SERVICESADVOCACY$18,645
EAST ASIA AND THE PACIFIC02PROGRAM SERVICESCONFERENCES AND ADVOCACY$499,156
NORTH AMERICA00PROGRAM SERVICESCONFERENCES AND ADVOCACY$1,469
SOUTH AMERICA03PROGRAM SERVICESCONFERENCES AND ADVOCACY$229,294
FieldValueIRS element (for citing)
Subtotal Offices0SubtotalOfficesCnt
Subtotal Employees8SubtotalEmployeesCnt
Continutation Total Office0ContinutationTotalOfficeCnt
Continutation Total Employee0ContinutationTotalEmployeeCnt
Total Office0TotalOfficeCnt
Total Employee8TotalEmployeeCnt
Subtotal Spent$1,034,667SubtotalSpentAmt
Continuation Spent$0ContinuationSpentAmt
Total Spent$1,034,667TotalSpentAmt
Transfer To Foreign Corp0TransferToForeignCorpInd
Interest In Foreign Trust0InterestInForeignTrustInd
Foreign Corp Ownership0ForeignCorpOwnershipInd
Passive Foreign Investmest Co0PassiveForeignInvestmestCoInd
Foreign Partnership0ForeignPartnershipInd
Boycott Countries0BoycottCountriesInd

Schedule I IRS990ScheduleI

FieldValueIRS element (for citing)
Grant Records MaintainedYes (1)GrantRecordsMaintainedInd

Recipient Table RecipientTable (26 entries)

Address Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdRecipient EINRecipientEINIRC SectionIRCSectionDescCash GrantCashGrantAmtPurpose Of GrantPurposeOfGrantTxt
INFORMATION TECHNOLOGY AND INNOVATION FOUNDATION
1101 K STREET SUITE 610WASHINGTONDC20005204403497501(C)(3)$25,000GENERAL SUPPORT
US CHAMBER OF COMMERCE
1615 H STREET NWWASHINGTONDC20062530045720501(C)(6)$40,000GENERAL SUPPORT
AMERICAN ENTERPRISE INSTITUTE FOR PBULIC POLICY RESEARCH
1150 17TH STREET NWWASHINGTONDC20036530218495501(C)(3)$25,000GENERAL SUPPORT
TRUSTEES OF TUFTS COLLEGE
75 KNEELAND STREET SUITE 1100BOSTONMA02111042103634501(C)(3)$11,000SPONSORSHIP
GEORGE MASON UNIVERSITY FOUNDATION INC
4400 UNIVERSITY DRIVEFAIRFAXVA22030541603842501(C)(3)$15,000GENERAL SUPPORT
WASHINGTON LEGAL FOUNDATION
2009 MASSACHUSETTS AVENUE NWWASHINGTONDC20036521071570501(C)(3)$10,000GENERAL SUPPORT
NATIONAL COALITION FOR CANCER SURVIVORSHIP
1010 WAYNE AVENUE SUITE 315SILVER SPRINGMD20910850357897501(C)(3)$15,000GENERAL SUPPORT
BIOFLORIDA INC
525 OKEECHOBEE BLVD STE 1500WEST PALM BEACHFL33401593436638501(C)(6)$5,500SPONSORSHIP
BIO NEBRASKA LIFE SCIENCES ASSOCIATION
9290 W DOGE ROAD SUITE 104OMAHANE68114202214508501(C)(6)$7,500SPONSORSHIP
PENNSYLVANIA BIOTECHNOLOGY ASSOCIATION
650 E SWEDESFORD ROAD SUITE 190WAYNEPA19087251621500501(C)(6)$20,000SPONSORSHIP
DELAWARE BIOSCIENCE ASSOCIATION
1 INNOVATION WAY SUITE 300NEWARKDE19711204147195501(C)(6)$6,000SPONSORSHIP
SOUTH CAROLINA BIOTECH ASSOCIATION
411 UNIVERSITY RIDGE SUITE AGREENVILLESC29601200613951501(C)(3)$10,000SPONSORSHIP
GEORGIA BIOSCIENCES ORGANIZATION
1199 EUCLID AVENUE NEATLANTAGA30307273855537501(C)(6)$10,000GENERAL SUPPORT
MICHIGAN BIOSCIENCES INDUSTRY ASSOCIATION
3520 GREEN ROAD SUITE 150ANN ARBORMI48105383142021501(C)(6)$7,500GENERAL SUPPORT
GLOBAL HEALTHY LIVING FOUNDATION INC
515 NORTH MIDLAND AVEUPPER NYACKNY10960204039120501(C)(3)$15,000SPONSORSHIP
LEUKEMIA & LYMPHOMA SOCIETY
3601 EISENHOWER AVNEUE SUITE 400ALEXANDRIAVA22304135644916501(C)(3)$25,000SPONSORSHIP
AMERICAN CANCER SOCIETY
1710 WEBSTER STREETOAKLANDCA94612131788491501(C)(3)$10,000SPONSORSHIP
SOCIETY FOR WOMENS HEALTH RESEARCH
1025 CONNECTICUT AVE NW SUITE 601WASHINGTONDC20036521694732501(C)(3)$15,000SPONSORSHIP
NATIONAL MULTIPLE SCIEROSIS SOCIETY
1800 M STREET NW SUITE 750 SOUTHWASHINGTONDC20036530237585501(C)(3)$6,500SPONSORSHIP
NATIONAL ORGANIZATION FOR RARE DISORDERS INC
55 KENOSIA AVENUEDANBURYCT06810133223946501(C)(3)$10,000SPONSORSHIP
THE JAMES BEARD FOUNDATION
167 WEST 12TH STREETNEW YORKNY10011132752108501(C)(3)$100,000GENERAL SUPPORT
ALLIANCE FOR PATIENT ACCESS
6227 EAGLE RIDGE ROADBETTENDORFIA52722205130312501(C)(4)$30,000PROGRAM ACTIVITIES
ALLIANCE FOR AGING RESEARCH
1700 K STREET NW SUITE 740WASHINGTONDC20006541379174501(C)(3)$10,000SPONSORSHIP
THE MILKEN INSTITUTE
1250 FOURTH STREET 2ND FLOORSAN MONICACA90401954240775501(C)(3)$20,000SPONSORSHIP
THE CONGRESSIONAL HUNGER CENTER
400 N CAPITOL ST NW SG100WASHINGTONDC20001521842738501(C)(3)$10,000SPONSORSHIP
COMPETITIVE ENTERPRISE INSTITUTE
1899 L ST NW 12TH FLOORWASHINGTONDC20036521351785501(C)(3)$10,000SPONSORSHIP
FieldValueIRS element (for citing)
Total501c3 Org18Total501c3OrgCnt
Total Other Org8TotalOtherOrgCnt

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePART I, LINE 2:FormAndLineReferenceDesc
ExplanationBIO RELIES ON THE REQUIRED QUALIFICATIONS OF THE GRANT RECIPIENTS TO PROVIDE ASSURANCE OF PROPER USAGE. IN SOME CASES, BIO PERSONNEL ATTEND EVENTS AND RECEIVE ACKNOWLEDGEMENTS RELATED TO THE FUNDS GRANTED.ExplanationTxt

Schedule J IRS990ScheduleJ

FieldValueIRS element (for citing)
First Class Or Charter TravelYes (X)FirstClassOrCharterTravelInd
Travel For CompanionsYes (X)TravelForCompanionsInd
Club Dues Or FeesYes (X)ClubDuesOrFeesInd
Written Policy Ref T And E ExpnssYes (1)WrittenPolicyRefTAndEExpnssInd
Substantiation RequiredYes (1)SubstantiationRequiredInd
Compensation CommitteeYes (X)CompensationCommitteeInd
Independent ConsultantYes (X)IndependentConsultantInd
Form990 Of Other OrganizationsYes (X)Form990OfOtherOrganizationsInd
Written Employment ContractYes (X)WrittenEmploymentContractInd
Compensation SurveyYes (X)CompensationSurveyInd
Board Or Committee ApprovalYes (X)BoardOrCommitteeApprovalInd
Severance Payment0SeverancePaymentInd
Supplemental Nonqual Rtr PlanYes (1)SupplementalNonqualRtrPlanInd
Equity Based Comp Arrngm0EquityBasedCompArrngmInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (11 entries)

TitleTitleTxtBase Compensation Filing OrgBaseCompensationFilingOrgAmtCompensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmtBonus Filing OrganizationBonusFilingOrganizationAmountBonus Related OrganizationsBonusRelatedOrganizationsAmtOther Compensation Filing OrgOtherCompensationFilingOrgAmtOther Compensation Rltd OrgsOtherCompensationRltdOrgsAmtDeferred Compensation Flng OrgDeferredCompensationFlngOrgAmtDeferred Comp Rltd OrgsDeferredCompRltdOrgsAmtNontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmtNontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmtTotal Compensation Filing OrgTotalCompensationFilingOrgAmtTotal Compensation Rltd OrgsTotalCompensationRltdOrgsAmtComp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmtComp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt
JAMES GREENWOOD
CEO & PRESIDENT$1,112,623$0$672,000$0$1,501,407$0$30,251$0$10,768$0$3,327,049$0$1,351,850$0
JOANNE DUNCAN
CFO & SVP, FINANCE & ADMIN$320,536$0$104,343$0$0$0$30,251$0$30,106$0$485,236$0$0$0
A SCOTT WHITAKER
COO$604,992$0$197,837$0$0$0$118,571$0$27,752$0$949,152$0$0$0
THOMAS DILENGE
GENERAL COUNSEL & HEAD OF PUBLIC POL$418,439$0$136,833$0$0$0$30,251$0$28,673$0$614,196$0$0$0
FREDERICK BITTENBENDER
EVP, PUBLIC AFFAIRS$385,455$0$126,832$0$0$0$30,251$0$26,010$0$568,548$0$0$0
AMY FINAN
SVP, BUSINESS DEVELOPMENT$314,626$0$105,714$0$0$0$30,251$0$16,091$0$466,682$0$0$0
BRENT ERICKSON
EVP, INDUSTRIAL & ENVIRONMENTAL$358,006$0$116,819$0$0$0$30,251$0$18,198$0$523,274$0$0$0
CARTIER ESHAM
EVP, EMERGING COMPANIES$296,217$0$90,720$0$0$0$30,251$0$12,716$0$429,904$0$0$0
JOSEPH DAMOND
SVP, INTERNATIONAL AFFAIRS$332,466$0$108,358$0$0$0$30,251$0$29,228$0$500,303$0$0$0
BRENT DELMONTE
SVP, FEDERAL GOVERNMENT RELATIONS$388,752$0$126,889$0$0$0$30,251$0$16,576$0$562,468$0$0$0
SARA RADCLIFFE
SVP, HEALTH$372,109$0$121,643$0$0$0$30,251$0$22,923$0$546,926$0$0$0

Supplemental Information Detail SupplementalInformationDetail (2 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
PART I, LINE 1AJAMES GREENWOOD NOT INCLUDED IN TAXABLE COMPENSATION TO THE INDIVIDUAL: - FIRST CLASS OR CHARTER TRAVEL - $33,836 - HEALTH OR SOCIAL CLUB DUES - $5,000 INCLUDED IN TAXABLE COMPENSATION TO THE INDIVIDUAL: - TRAVEL FOR COMPANIONS - $16,794
PART I, LINE 4BJAMES GREENWOOD - 457(F) $1,463,424 SCOTT WHITAKER - 457(F) $88,320

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (11 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
FORM 990, PART IV, LINE 11F:AS PART OF THE AUDIT CONDUCTED FOR THE ORGANIZATION A FIN 48 (ASC 740) ANALYSIS IS COMPLETED. IT WAS DETERMINED THAT NO UNCERTAIN TAX POSITIONS EXISTED AND AS SUCH THERE IS NO FOOTNOTE IN THE FINANCIAL STATEMENTS THAT DISCUSSES FIN 48 (ASC 714).
FORM 990, PART VI, SECTION A, LINE 1THE BOARD OF DIRECTORS SHALL DESIGNATE, BY RESOLUTION AND WITH A QUORUM PRESENT, NOT MORE THAN NINETEEN (19) DIRECTORS OF THE BOARD TO ACT AS AN EXECUTIVE COMMITTEE. THE EXECUTIVE COMMITTEE SHALL CONSIST OF THE SEVEN (7) ELECTED OFFICERS OF THE ORGANIZATION (AS DEFINED IN ARTICLE VIII); THE IMMEDIATE PAST CHAIR OF THE ORGANIZATION; THE VICE CHAIRS OF EACH SECTION'S GOVERNING BOARD; AND THE BALANCE BEING AT-LARGE DIRECTORS FROM THE FULL BOARD. IF THE IMMEDIATE PAST CHAIR IS NO LONGER ELIGIBLE TO SERVE ON THE FULL BOARD, AN ADDITIONAL AT-LARGE DIRECTOR FROM THE FULL BOARD SHALL BE SELECTED FOR THE EXECUTIVE COMMITTEE. THE EXECUTIVE COMMITTEE SHALL HAVE, AND BE AUTHORIZED TO EXERCISE, ALL POWERS OF THE FULL BOARD, EXCEPT: (A) THE POWER TO ELECT OR REMOVE ELECTED OFFICERS OR DIRECTORS, TO CHANGE THE SIZE OF THE BOARD, TO CHANGE ELIGIBILITY, QUALIFICATIONS OR RIGHTS OF MEMBERSHIP, TO APPROVE THE FINANCIAL BUDGET FOR THE ORGANIZATION, OR TO MAKE DETERMINATIONS AS TO DIRECTOR AND OFFICER COMPENSATION, WHERE APPLICABLE; AND (B) THE POWER TO AMEND THE ARTICLES OF INCORPORATION OR THE BYLAWS OF THE ORGANIZATION. THE EXECUTIVE COMMITTEE SHALL REPORT TO THE BOARD OF DIRECTORS AT THE NEXT MEETING ON ITS ACTIONS SINCE THE LAST MEETING OF THE FULL BOARD AND SUBMIT SUCH ACTIONS FOR RATIFICATION BY THE BOARD OF DIRECTORS.
FORM 990, PART VI, SECTION A, LINE 2BASED ON RESPONSES TO A SURVEY DISTRIBUTED TO EACH MEMBER OF BIO'S BOARD OF DIRECTORS, TWO DIRECTORS - KRISTINE PETERSON AND DANIEL JUNIUS -- HAD A BUSINESS RELATIONSHIP IN 2014 AS DEFINED BY THE FORM 990 INSTRUCTIONS
FORM 990, PART VI, SECTION A, LINE 4THE BYLAWS WERE AMENDED ON JUNE 23, 2014, TO ENACT THE FOLLOWING CHANGES: (1) TO ALTER THE SIZE AND COMPOSITION OF THE HEALTH SECTION GOVERNING BOARD SO AS TO PERMIT GREATER PARTICIPATION BY LARGE FIRMS MEMBERS, WHILE ENSURING THAT EMERGING AND ESTABLISHED COMPANIES MAINTAIN A MAJORITY OF AVAILABLE SEATS ON THE GOVERNING BOARD AND ON THE RELEVANT NOMINATING COMMITTEE; AND (2) TO ELIMINATE THE RESTRICTIONS REGARDING THE PERCENTAGE OF "DESIGNATED OFFICERS" FROM LARGE FIRMS ON THE SECTION GOVERNING BOARDS, WHILE PROVIDING ADDITIONAL GUIDANCE TO THE RELEVANT NOMINATING COMMITTEES ON THE FACTORS THAT ARE RELEVANT TO ASSESSING THE CREDENTIALS OF PROPOSED DESIGNATED OFFICERS.
FORM 990, PART VI, SECTION A, LINE 6THE MEMBERS OF THE ORGANIZATION SHALL BE DIVIDED INTO FOUR CLASSES; CORE MEMBERS, ASSOCIATE MEMBERS, AFFILIATE MEMBERS, AND CENTER MEMBERS, DEFINED AS FOLLOWS: (A) CORE MEMBERS. ANY CORPORATION, PARTNERSHIP, ASSOCIATION, OR OTHER ENTITY ORGANIZED FOR PROFIT, A SUBSTANTIAL PERCENTAGE OF WHOSE BUSINESS ACTIVITIES INVOLVE BIOTECHNOLOGY, GENOMICS, BIOINFORMATICS OR RELATED NEW TECHNOLOGIES, IS ELIGIBLE FOR MEMBERSHIP. CORE MEMBERS ARE THOSE ENTITIES THAT UTILIZE BIOTECHNOLOGY, GENOMICS, BIOINFORMATICS OR OTHER RELATED NEW TECHNOLOGIES IN RESEARCH, DEVELOPMENT, TESTING, MANUFACTURING, OR SALES OF PRODUCT OR INFORMATION, AS WELL AS OTHER FIRMS THE BOARD SO CHARACTERIZES AND PLACES IN THIS CATEGORY. CORE MEMBERS SHALL BE GROUPED IN THE FOLLOWING SUBCATEGORIES: (I) EMERGING COMPANIES, WHICH ARE FIRMS THAT EMPLOY LESS THAN 350 PERSONS AND THAT DO NOT HAVE A THERAPEUTIC OR DIAGNOSTIC PRODUCT APPROVED FOR SALE IN THE U.S. MARKET; (II) ESTABLISHED FIRMS, WHICH ARE THOSE FIRMS THAT EMPLOY 350 OR MORE PERSONS OR THAT HAVE A THERAPEUTIC OR DIAGNOSTIC PRODUCT APPROVED FOR SALE IN THE U.S. MARKET; AND (III) LARGE FIRMS, WHICH ARE ESTABLISHED FIRMS THAT HAVE ANNUAL WORLDWIDE SALES OF BIOTECHNOLOGY PRODUCTS IN EXCESS OF $1.5 BILLION; AND (IV) NON-DOMESTIC COMPANIES, WHICH ARE CORE MEMBERS WITHOUT SIGNIFICANT OPERATIONS IN THE UNITED STATES OR SIGNIFICANT COLLABORATIONS WITH A U.S. ENTITY. (B) ASSOCIATE MEMBERS. ANY CORPORATION, PARTNERSHIP, ASSOCIATION, OR OTHER ENTITY ORGANIZED FOR PROFIT, A SUBSTANTIAL PORTION OF WHOSE ACTIVITIES INVOLVE PROVIDING SERVICES OR PRODUCTS OF BENEFIT TO COMPANIES WHOSE PRINCIPAL BUSINESS IS BIOTECHNOLOGY, IS ELIGIBLE FOR ASSOCIATE MEMBERSHIP. ASSOCIATE MEMBERS ARE THOSE COMMERCIAL ENTITIES WHICH DO NOT NECESSARILY UTILIZE BIOTECHNOLOGY; E.G. TECHNICAL SUPPORT, EQUIPMENT, CONSTRUCTION, ACCOUNTING, AND LAW FIRMS THAT SERVICE THE BIOTECHNOLOGY INDUSTRY, AS WELL AS OTHER FIRMS THAT THE BOARD CHARACTERIZES AND PLACES IN THIS CATEGORY. (C) AFFILIATE MEMBERS. ANY GOVERNMENTAL OR NONPROFIT ENTITY OR COUNTRY, STATE OR REGIONAL INDUSTRY, TRADE OR PROFESSIONAL ASSOCIATION WITH AN INTEREST IN, OR A MANDATE TO PROMOTE THE DEVELOPMENT OF, BIOTECHNOLOGY IS ELIGIBLE FOR AFFILIATE MEMBERSHIP. THERE SHALL BE NO SIZE TESTS APPLIED TO AFFILIATE MEMBER APPLICANTS. (D) CENTER MEMBERS. ANY INSTITUTION, NOT GENERALLY ELIGIBLE FOR CORE MEMBERSHIP THAT IS SPONSORED BY A STATE, REGION, OR ACADEMIC INSTITUTION AND WORKS IN SUPPORT OF COMMERCIAL BIOTECHNOLOGY MAY BE ELIGIBLE FOR CONSIDERATION AS A CENTER MEMBER.
FORM 990, PART VI, SECTION A, LINE 7AAT ALL MEMBERSHIP MEETINGS OF THE ORGANIZATION, EACH CURRENT MEMBER SHALL HAVE ONE (1) VOTE AND MAY TAKE PART IN THE VOTING IN PERSON OR BY PROXY. FOR EACH SECTION IN WHICH THE MEMBER PARTICIPATES, EACH MEMBER SHALL HAVE THE RIGHT TO VOTE ON THE ELECTION OF DIRECTORS FOR THE SECTION GOVERNING BOARD, BUT SHALL HAVE NO OTHER VOTING RIGHTS EXCEPT ON MATTERS BROUGHT TO THE MEMBERSHIP BY ANY SUCH GOVERNING BOARD OR THE ORGANIZATION'S BOARD OF DIRECTORS.
FORM 990, PART VI, SECTION B, LINE 11THE FORM 990 AND RELATED SCHEDULES ARE PREPARED BY THE ORGANIZATION'S CERTIFIED PUBLIC ACCOUNTANTS UNDER THE GUIDANCE OF THE CFO. THE CFO AND THE CONTROLLER THOROUGHLY REVIEW ALL CALCULATIONS AND SCHEDULES TO CONFIRM THEY REFLECT THE ACTUAL FINANCIAL RESULTS OF THE ORGANIZATION. THE COMPLETE FORM 990 IS THEN REVIEWED INTERNALLY BY THE CEO, COO, CFO, AND CONTROLLER IN CONSULTATION WITH LEGAL COUNSEL AND, AS APPROPRIATE, FURTHER CONSULTATION WITH THE ORGANIZATION'S CERTIFIED PUBLIC ACCOUNTANTS. FINALLY, ONCE ALL INTERNAL REVIEWS ARE COMPLETED, THE FORM 990 IS PROVIDED TO THE CHAIRMAN OF THE BOARD AND ALL MEMBERS OF THE BIO EXECUTIVE COMMITTEE FOR THEIR REVIEW, QUESTIONS AND/OR COMMENTS, PRIOR TO FILING WITH THE IRS.
FORM 990, PART VI, SECTION B, LINE 12CBIO TAKES SEVERAL STEPS TO ADDRESS COMPLIANCE BY EMPLOYEES AND DIRECTORS WITH ITS CONFLICTS OF INTEREST POLICY. BIO TRAINS ALL NEW EMPLOYEES AND DIRECTORS ON VARIOUS ASPECTS OF BIO'S COMPLIANCE PROGRAM, INCLUDING CONFLICTS OF INTEREST, AND BIO'S WRITTEN CONFLICTS OF INTEREST POLICY REQUIRES ALL EMPLOYEES TO DISCLOSE ANY OUTSIDE PERSONAL BUSINESS INTERESTS TO THEIR SUPERVISOR. BIO'S GENERAL COUNSEL REGULARLY ADVISES BIO'S EXECUTIVES AND SUPERVISORS ON SUCH MATTERS. BIO ALSO CONTRACTS WITH AN INDEPENDENT ORGANIZATION TO PROVIDE EMPLOYEES AND OTHERS WITH THE ABILITY TO FILE ANONYMOUS REPORTS CONCERNING THE VIOLATION OF ANY LAWS OR BIO POLICIES, INCLUDING ALLEGATIONS OF POTENTIAL CONFLICTS OF INTEREST, AND BIO HAS A PROCESS IN PLACE TO FOLLOW UP ON ANY SUCH COMPLAINTS IN A TIMELY AND THOROUGH MANNER. FURTHER, BIO UNDERTAKES A QUESTIONNAIRE SENT ANNUALLY TO EACH MEMBER OF ITS BOARD OF DIRECTORS SEEKING DISCLOSURE OF ANY POTENTIAL CONFLICTS OF INTERESTS THEY MAY HAVE, OR THEIR FAMILY MEMBERS MAY HAVE, ASSOCIATED WITH BUSINESSES OR ORGANIZATIONS THAT DO BUSINESS WITH BIO. POTENTIAL CONFLICTS ARE MONITORED AND REVIEWED AT THE MANAGEMENT AND SENIOR MANAGEMENT LEVEL OF THE ORGANIZATION, AND DEPENDING ON THE CONFLICT, DETERMINATIONS MAY BE MADE AT THE BOARD OR SENIOR MANAGEMENT LEVEL. A CONFLICT AT THE BOARD LEVEL WILL NORMALLY RESULT IN RECUSAL OF THE INDIVIDUAL FROM PARTICIPATION OR ACTIVITIES WITH RESPECT TO THE RELEVANT SUBJECT MATTER. AT THE STAFF LEVEL, THE APPLICABLE BIO SUPERVISOR IS INFORMED OF THE POTENTIAL CONFLICT AND IS REQUIRED TO TAKE ALL APPROPRIATE STEPS TO ENSURE THAT THE INDIVIDUAL DOES NOT PARTICIPATE IN, OR RECEIVE CONFIDENTIAL INFORMATION RELATING TO, ANY BIO ACTIVITY RELATED TO THE SUBJECT MATTER OF THE CONFLICT, UP TO AND INCLUDING, WHERE APPROPRIATE, TERMINATION OF SUCH EMPLOYEE.
FORM 990, PART VI, SECTION B, LINE 15ATHE PERFORMANCE AND COMPENSATION OF THE PRESIDENT AND CEO OF BIO FOR 2014 WAS REVIEWED AND DETERMINED IN A PROCESS THAT WAS LED BY THE CHAIRMAN OF THE BOARD AND INVOLVED THE FULL EXECUTIVE COMMITTEE OF THE BOARD. THE BIO EXECUTIVE COMMITTEE, WHICH IS COMPRISED OF INDEPENDENT BIO BOARD MEMBERS, LEADS AND UNDERTAKES THIS ANNUAL PROCESS. IF NEEDED IN CARRYING OUT THIS PROCESS, THE MEMBERS OF THE EXECUTIVE COMMITTEE CAN BE ASSISTED AND COUNSELED BY BOTH INDEPENDENT OUTSIDE LEGAL COUNSEL WHO IS AN EXPERT IN THIS AREA OF THE LAW, AND AN INDEPENDENT OUTSIDE CONSULTANT THAT PROVIDES BENCHMARKING SERVICES AND INFORMATION ON EXECUTIVE COMPENSATION ISSUES. THE UNDERLYING EXECUTIVE EMPLOYMENT AGREEMENT WAS REVISED AND EXTENDED IN 2014, IN CONSULTATION WITH EXTERNAL INDEPENDENT LEGAL AND COMPENSATION CONSULTANTS AND WITH THE FULL BOARD OF DIRECTORS, AND WITH FINAL APPROVAL BY THE EXECUTIVE COMMITTEE OF THE BOARD. BASED ON THE EXECUTIVE COMMITTEE'S EVALUATION OF THE PRESIDENT AND CEO'S PERFORMANCE FOR 2014, INCLUDING REVIEW OF HIS OBJECTIVES AND SELF-ASSESSMENT, THE COMMITTEE DETERMINED THE APPROPRIATE AMOUNT FOR THE DISCRETIONARY COMPONENT OF HIS COMPENSATION FOR THAT YEAR, IN ACCORDANCE WITH PROVISIONS OF THE EXECUTIVE AGREEMENT. THE PROCESS OF THIS REVIEW WAS DOCUMENTED IN THE JANUARY 2014 EXECUTIVE COMMITTEE MEETING MINUTES. IN ADDITION, THE INFORMATION RELATED TO COMPENSATION CHANGES ARE DISCUSSED IN THE EXECUTIVE AGREEMENT OR COMMUNICATED TO THE CFO VIA EMAIL BY THE CHAIRMAN OF THE BOARD. FORM 990, PART VI, SECTION B, LINE 15B: DECISIONS REGARDING THE COMPENSATION FOR OFFICERS AND KEY EMPLOYEES OF THE ORGANIZATION ARE NEGOTIATED INDIVIDUALLY AND ARE PERFORMANCE-BASED, IN ACCORDANCE WITH AN ANNUAL WRITTEN EVALUATION PROCESS THAT HAS BEEN ESTABLISHED FOR ALL EMPLOYEES OF THE ORGANIZATION. THE CHIEF OPERATING OFFICER LEADS AND UNDERTAKES THIS PROCESS, IN COORDINATION WITH THE PRESIDENT & CEO. AN INDEPENDENT CONSULTANT PROVIDES COMPARATIVE BENCHMARKING SERVICES FOR SENIOR MANAGEMENT POSITIONS, AND OTHER INFORMATION ON COMPENSATION ISSUES, TRENDS, POLICIES, AND BEST PRACTICES FOR USE BY THE ORGANIZATION. THE ORGANIZATION ALSO HAS AN ESTABLISHED COMPENSATION POLICY FOR ALL OF ITS EMPLOYEES, WHICH SETS FORTH THE GENERAL PARAMETERS GOVERNING BIO'S COMPENSATION PRACTICES.
FORM 990, PART VI, SECTION C, LINE 19THE ORGANIZATION DOES NOT MAKE ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC.
FORM 990, PART XI, LINE 9:CBI LOBBYING FUND REVENUE 856,950. CBI LOBBYING FUND EXPENSE -828,095. FOOD & AG INITIATIVES REVENUE 32,064. FOOD & AG INITIATIVES EXPENSES -32,064. FOOD & AG LEGAL FUND REVENUE 1,218,240. FOOD & AG LEGAL FUND EXPENSES -1,218,240. BIOSIMILARS REVENUE 469,000. BIOSIMILARS EXPENSE -457,368.